Patheon Inc.
2100 Syntex Court
Mississauga
Ontario
L5N 7K9
Canada
Tel: 888-PATHEON or 905-821-4001
Fax: 905-812-6791
Website: http://www.patheon.com/
Email: patheon@patheon.com
113 articles about Patheon Inc.
-
Patheon Inc.'s Greenville Plant To Add 488 Well-Paying Jobs
10/6/2014
-
Relypsa, Inc. Announces Commercial Manufacturing Agreement With Patheon Inc.
9/9/2014
-
Patheon Inc. Restructure Complete; New Company, DPx Expects $2 Billion In Annual Sales
3/12/2014
-
Patheon Inc. Shareholders Approve Plan Of Arrangement
3/6/2014
-
Patheon Inc. Files Proxy Statement For Special Meeting Of Shareholders
2/5/2014
-
Patheon Inc. Reports Fiscal 2013 Results
1/13/2014
-
Patheon Inc. To Be Taken Private For $9.32 Per Share In Cash
11/19/2013
-
Patheon Inc. to be a Significant Presence at AAPS Annual Meeting and Exposition
10/29/2013
-
Patheon Inc. Reports Fiscal 2013 Second Quarter Results
6/3/2013
-
Patheon Inc. Announces Date of Fiscal 2013 Second Quarter Financial Results
5/21/2013
-
Patheon Inc. Reports Fiscal 2013 First Quarter Results
3/8/2013
-
Patheon Inc. Release: Aqeel Fatmi Appointed Executive Vice President, Global Research & Development and Chief Scientific Officer
1/9/2013
-
Patheon Inc. Successfully Completes Rights Offering
1/2/2013
-
Patheon Inc. Reports Fourth Quarter and Full Fiscal 2012 Results
12/17/2012
-
Patheon Inc. Announces Date of Full Year Fiscal 2012 Financial Results
12/4/2012
-
Patheon Inc. Commences Cash Tender Offer for Outstanding Senior Secured Notes
11/27/2012
-
Patheon Inc. Announces a Change to Its PDS Management Structure
8/14/2012
-
ADVENTRX Pharmaceuticals Inc. Announces Manufacturing Agreement With Patheon Inc. to Manufacture ANX-188 Drug Product
6/26/2012
-
Patheon Announces Annual and Special Shareholder Meeting Web Cast
3/13/2012
-
Patheon Reports Fiscal 2012 First Quarter Results
3/12/2012